Latest News
Click here to find out more! Vectibix® Improves Outcome of Previously Treated Colorectal Cancer
Feb 03, 2010
Researchers involved in an international randomized trial have reported that the addition of Vectibix® (panitumumab) to FOLFIRI (5-fluorourcil, Camptosar® [irinotecan], and leucovorin) improves progression-free survival (PFS) in patients with colorectal cancer with wild-type KRAS who are receiving second-line therapy. These results were presented at the 2010 ASCO Gastrointestinal Cancers Symposium.
« More
- (Feb-03) - National Post - A man and his cause
- (Feb-03) - National Post - Colorectal cancer preventable, treatable and beatable!
- (Jan-29) - Pulse - Low levels of vitamin D predict colorectal cancer
- (Jan-29) - Colorectal Cancer Screening Approach Studied in Seniors
- (Jan-25) - Iron Therapy Reduces Hospital Stay in Colorectal Cancer Surgery Patients: Presented at ASCO-GI
- (Jan-25) - Panitumumab/FOLFIRI improved PFS in wild-type KRAS metastatic colorectal cancer | HemOncToday
- (Jan-25) - New evidence shows selenium and omega-3s prevent colon cance
- (Jan-25) - Medical News: ASCO GI: Antibody Slows Metastatic Colon Cancer - in Meeting Coverage, ASCO GI from MedPage Today
- News Archives...
Upcoming Event
Giant Golon Tour - Ottawa
Touring Canada in 2010 check for dates!
Upcoming Locations:
Jan 11-12 2010 - North Bay Gate Shopping Center
Jan 16-17 2010 - London White Oaks Mall
Jan 19-20 2010 - Windsor Devonshire Mall
Jan 22-23 2010 - St Catherines Pen Center Mall
« More